Treatment Outcome After Surgical Treatment of Osteoid Osteoma

Sponsor
Universitaire Ziekenhuizen Leuven (Other)
Overall Status
Completed
CT.gov ID
NCT01466010
Collaborator
(none)
150
1
144
1

Study Details

Study Description

Brief Summary

Purpose of the study:

To retrospectively determine the clinical results in an unselected group of consecutive patients with osteoid osteoma treated by surgery.

Materials and Methods:

In 150 consecutive patients with clinical and/or radiological evidence for osteoid osteoma at any location, the clinical symptoms and imaging findings (radiographs and computed tomography (CT)) were assessed before and after surgery. There were no exclusion criteria for this study. A good response was defined as disappearance of symptoms that were manifested at presentation and were attributed to osteoid osteoma. Clinical assessment after the procedure was performed prior to discharge; within 2 weeks after the procedure; and at 3, 6, and 12 months follow-up. After 24 months, a postal questionnaire was used for assessment. Radiographic evaluation (radiographs and thin-slice CT) was performed routinely pre-operatively and one year after surgery.

In case of persisting or recurring symptoms the follow-up protocol was again performed according to the initial protocol.

All patients gave their informed consent both for the surgical intervention as for the use of their patient data in this retrospective study.

Condition or Disease Intervention/Treatment Phase
  • Procedure: surgical removal of osteoid osteoma

Study Design

Study Type:
Observational
Actual Enrollment :
150 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Treatment Outcome After Surgical Treatment of Osteoid Osteoma, a Retrospective Study
Study Start Date :
Jan 1, 1998
Actual Study Completion Date :
Jan 1, 2010

Arms and Interventions

Arm Intervention/Treatment
osteoid osteoma

patients with osteoid osteoma at any location

Procedure: surgical removal of osteoid osteoma
surgery for osteoid osteoma: this may include curettage or en-bloc resection of the lesion

Outcome Measures

Primary Outcome Measures

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    2 Years to 70 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • patient with osteoid osteoma at any location.
    Exclusion Criteria:
    • none.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 UZ Leuven Dept of Radiology Leuven Vlaams Brabant Belgium 3000

    Sponsors and Collaborators

    • Universitaire Ziekenhuizen Leuven

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Universitaire Ziekenhuizen Leuven
    ClinicalTrials.gov Identifier:
    NCT01466010
    Other Study ID Numbers:
    • S53583
    First Posted:
    Nov 6, 2011
    Last Update Posted:
    Nov 6, 2011
    Last Verified:
    Sep 1, 2011
    Keywords provided by Universitaire Ziekenhuizen Leuven
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Nov 6, 2011